Showing 221 - 240 results of 101,348 for search '(( i et decrease ) OR ( 5 ((((ng decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.75s Refine Results
  1. 221

    Increases in 1,5-anhydrosorbitol and decreases in ascorbic acid following RYGB. by David M. Mutch (37665)

    Published 2013
    “…B) For ascorbic acid, the ANOVA model did not detect group-specific changes over time (no group:time interaction), but indicated significant decreases from T0 to T6 in both groups. Overall, 1,5-anhydrosorbitol and ascorbic acid were significantly different at each time point between OB and OB/D subgroups (p<0.01, see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007905#pone-0007905-t002" target="_blank"><b>TABLE 2</b></a>).…”
  2. 222
  3. 223
  4. 224
  5. 225
  6. 226
  7. 227
  8. 228
  9. 229
  10. 230

    Comparative analysis of the decrease of conjunctivochalasis in various studies. by Huba J. Kiss (769411)

    Published 2015
    “…[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0132656#pone.0132656.ref022" target="_blank">22</a>], 5: Lee et al. …”
  11. 231
  12. 232
  13. 233
  14. 234
  15. 235
  16. 236
  17. 237
  18. 238

    HRMECs treated with 3-Deazaneplanocin A (DZNep) chemical inhibitor demonstrated increased miR-200b and decreased VEGF expression. by Michael Anthony Ruiz (726055)

    Published 2015
    “…[NG = 5mM D-glucose, HG = 25mM D-glucose, NG+DMSO = 5mM D-glucose + 0.05% DMSO, HG+DMSO = 25mM D-glucose + 0.05% DMSO, NG+DZNEP = 5mM D-glucose + 5μM DZNep, HG+DZNEP = 25mM + 5μM DZNep; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to β-actin for VEGF and U6 for miR-200b, expressed as a fold change of NG].…”
  19. 239
  20. 240